Skip to main content
logo
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.450
-0.030 (-2.03%)
At close: Oct 8, 2026, 4:00 PM EDT
1.520
+0.070 (4.83%)
After-hours: Oct 8, 2026, 7:30 PM EDT

Palisade Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
25335055818
Market Cap Growth
37.25%7572.39%-16.56%-31.77%-54.57%-
Enterprise Value
128345-3-9-54
Last Close Price
1.452.351.658.8578.00975.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
505.38--21.88--
PB Ratio
2.072.710.610.480.642.40
P/TBV Ratio
2.082.710.610.480.642.40

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.020.030.030.03
Net Debt / Equity Ratio
-1.03-1.03-1.29-1.07-0.96-1.40
Net Debt / EBITDA Ratio
3.547.390.650.940.780.88
Net Debt / FCF Ratio
6.8812.290.791.080.900.70
Asset Turnover
0.01--0.02--
Quick Ratio
23.9628.833.044.874.594.26
Current Ratio
24.2628.953.245.154.894.61
Return on Equity (ROE)
-51.37%-24.52%-153.56%-103.40%-143.72%-20012.03%
Return on Assets (ROA)
-32.98%-15.54%-74.50%-53.85%-67.69%-94.46%
Return on Capital Employed (ROCE)
-29.00%-13.90%-194.40%-112.00%-120.10%-117.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.64%-4.79%-316.35%-224.87%-177.89%-150.84%
FCF Yield
-7.20%-3.10%-267.16%-203.61%-166.78%-83.72%
Buyback Yield / Dilution
-4683.09%-3830.18%-210.62%-677.03%-370.85%-
SEC Filings: 10-K · 10-Q